Navigation Links
Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou
Date:4/25/2008

Inactivated Rabies Vaccine for Animals to be Produced in Changzhou Hi-Tech

District, China

CHANGZHOU, China, April 25 /Xinhua-PRNewswire/ -- A project for producing inactivated rabies animal vaccines was recently launched in Changzhou National High-tech District, east China's Jiangsu Province. This is a new product developed by a team of leading overseas scientists. It is reported that it is the first time for China will produce this kind of high-tech inactivated vaccine. This vaccine is expected to replace less effective attenuated rabies living vaccines manufactured in China as well as the more expensive imported products.

In this project, major products of a newly-founded company, Changzhou Tongtai Biopharmaceutical Co., Ltd., will be produced. The technological team is under the leadership of Fu Zhenfang, professor of the veterinary institute of Georgia University, U.S. and a talented scientific and technological professional, who was introduced to Changzhou in 2007. With a total investment of USD 10 million, the production and sales value are expected to reach 200 million. In the first phase, a production base and research center for biological products for animal use will be built, focusing on the inactivated rabies vaccine. If production and sales targets for the first phase are fulfilled, a production base for the bird flu vaccine and FMD vaccine (Foot-and-Mouth Disease) will be constructed.

Rabies is a contagious disease, which can be prevented but cannot be cured, threatening the life of both humans and animals. The death rate is almost 100%. About 55000 lives are taken by this disease in Asia and Africa each year. China has a high occurrence area of rabies. According to statistics, from 2003 to 2005, the number of deaths caused by rabies in China is over 2500 on average, which is the highest in terms of number and rate of death of all infectious diseases. Rabies in China mainly infects dogs and cats
'/>"/>

SOURCE National High-Tech District, Changzhou
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer
2. United BioSource Acquires Leading Publication Planning Software and Services Company
3. Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University
4. CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal
5. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
6. Dragon retains leading investor relations firm
7. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
8. Halogen Customers Shape Industry-Leading Employee Performance and Talent Management Solution
9. PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting
10. ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board
11. Cord Blood America CEO Matthew Schissler Interviewed by BIONOVA, Greeces Leading Biotech Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. This ... as a characteristic that can be objectively measured ... or pathogenic processes as well as pharmacological responses ...
(Date:9/2/2015)... Sept. 2, 2015  Neurotech Pharmaceuticals, Inc., announced ... the multicenter Phase 2 clinical trial of NT-503 ... of recurrent subfoveal choroidal neovascularization secondary to age ... unique vascular endothelial growth factor (VEGF) receptor protein ... "This landmark proof-of-concept study will evaluate NT-503 ...
(Date:9/2/2015)... ZIONA, Israel , September 2, 2015 ... BVXV) today announced the intent of the National Institute of ... Institutes of Health (NIH) within the Department of Health and ... to be held in the United States ... use of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as ...
(Date:9/2/2015)... ... 02, 2015 , ... The TS5-Q is designed for myriad ... to analysis of athletic performance. Producing high-resolution slow-motion video , the TS5-Q ... process with the naked eye. , Slow motion sequences are commonly seen ...
Breaking Biology Technology:Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3
... race to make solar cells cheaper and more ... on new designs that exploit nanostructures--materials engineered on ... Using nanotechnology, researchers can experiment with and control ... free electrons--properties that are important for the conversion ...
... 8 RxElite, Inc. (OTC,Bulletin Board: RXEI), a ... products, announced today that as permitted under,the registration ... stockholders to cease using the company,s Registration Statement ... 2008 prospectus until,further advised. This release corrects and ...
... expands SRA footprint in human health services around the ... ... overall,expansion in new markets, SRA International, Inc. (NYSE: SRX ) today,announced the ... President and Chief Financial Officer (CFO) of its new,Global Health Sector (GHS) organization. ...
Cached Biology Technology:New nanostructured thin film shows promise for efficient solar energy conversion 2New nanostructured thin film shows promise for efficient solar energy conversion 3/CORRECTION//- RxElite Temporarily Suspends Sales Under Its Registration Statement 2SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer 2SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer 3
(Date:8/19/2015)... 2015  VOXX International Corporation (Nasdaq: VOXX ... a Definitive Agreement to purchase the assets, inclusive ... leader EyeLock through an acquiring entity.  Upon consummation ... interest in the acquiring entity. The closing of ... diligence.  Expanding on its existing supply chain and ...
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
(Date:8/12/2015)... MINNETONKA, Minn. , Aug. 12, 2015   ... that supports the entire spectrum of clinical research, is ... ™ , the company,s comprehensive SaaS-based eClinical technology platform, ... growth during the first two quarters of 2015.   ... and second largest quarters measured by contract value sold ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2
... have uncovered a new cellular secret that may explain ... of cancers that makes treatment especially difficult. If the ... -- can be understood well enough to manipulate it, ... with metastatic cancers. , Significance of the Mayo ...
... exposure has already permanently damaged their skin cells, causing ... dark splotches and uneven skin tone over time. But ... known for treating arthritis ?can actually help stop the ... ones. , "These findings on glucosamine may impact the ...
... have taken a potentially powerful new therapy for treating ... the test tube and into animals by demonstrating it ... The research has particularly important implications for the estimated ... both nerves and blood vessels. , The therapy involves ...
Cached Biology News:Mayo Clinic researchers discover cancer cells may move via wave stimulation 2Mayo Clinic researchers discover cancer cells may move via wave stimulation 3Science finds new fix for UV-damaged skin in arthritis treatment 2Science finds new fix for UV-damaged skin in arthritis treatment 3Proteins spur diabetic mice models to grow blood vessels, nerves 2
... can be upgraded to the GenePix Autoloader ... analyzes, and saves results for up to ... when the batch is complete. Line-by-line autofocus ... slides. GenePix Pro gives you complete flexibility ...
... a fast, easy to use, reproducible and ... are 15 times faster and 5 times ... 5%). ,The VoluPAC tubes enable the determination ... a cell suspension, resulting in absolute data ...
... your microarray data using Asuragens bioinformatics expertise. ... consultation to extensive data analysis using the ... expertise in combination with the Gene Expression ... experiments., ,Normalization and basic statistical analysis including ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ...
Biology Products: